Skip to main content
ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · IEX Real-Time Price · USD
19.41
-0.05 (-0.26%)
May 31, 2024, 4:00 PM EDT - Market closed

ArriVent BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022
Cash & Equivalents
150.39163.37
Cash & Cash Equivalents
150.39163.37
Cash Growth
-7.95%-
Other Current Assets
9.5819.25
Total Current Assets
159.97182.62
Property, Plant & Equipment
0.290.14
Other Long-Term Assets
2.840.07
Total Long-Term Assets
3.130.21
Total Assets
163.1182.83
Accounts Payable
4.533.09
Current Debt
0.140.13
Other Current Liabilities
6.955.14
Total Current Liabilities
11.628.36
Long-Term Debt
0.180.01
Total Long-Term Liabilities
0.180.01
Total Liabilities
11.88.37
Total Debt
0.320.14
Debt Growth
128.06%-
Retained Earnings
-157.85-88.51
Shareholders' Equity
-153.19-85.11
Net Cash / Debt
150.07163.23
Net Cash / Debt Growth
-8.06%-
Net Cash Per Share
70.10127.82
Working Capital
148.34174.26
Book Value Per Share
-71.55-66.64
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).